Hologic Inc. (HOLX)
Hologic's Breast Health Rebounds, Takes Spotlight in Buyout Deal
After a strong Q4 rebound, HOLX's Breast Health takes center stage in the company's upcoming private equity takeover.
HOLX Stock Up on Q4 Earnings & Revenue Beat, Operating Margin Expands
Hologic posts solid Q4 gains with earnings and revenue beat, margin expansion, and a buyout deal by Blackstone and TPG.
Hologic (HOLX) Q4 Earnings and Revenues Beat Estimates
Hologic (HOLX) came out with quarterly earnings of $1.13 per share, beating the Zacks Consensus Estimate of $1.1 per share. This compares to earnings of $1.01 per share a year ago.
Hologic (HOLX) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for Hologic (HOLX) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
HOLX vs. ABT: Which Medical Technology Stock Is the Better Investment?
Hologic's $18.3B buyout deal and Abbott's strong growth across key segments set up a close contest for MedTech investors.
Gear Up for Hologic (HOLX) Q4 Earnings: Wall Street Estimates for Key Metrics
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Hologic (HOLX), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.
HOLX or IDXX: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Instruments stocks have likely encountered both Hologic (HOLX) and Idexx Laboratories (IDXX). But which of these two stocks is more attractive to value investors?
Buy, Hold or Sell Hologic Stock? Key Insights Ahead of Q4 Earnings
HOLX's fiscal Q4 2025 earnings may face limits as macro pressures and slow Diagnostics curb momentum.
Hologic Stock Rises as Report Says Blackstone and TPG in Advanced Takeover Talks
The maker of women's health products rejected a $16 billion offer from the parties in May.
Why the Market Dipped But Hologic (HOLX) Gained Today
Hologic (HOLX) reached $68.5 at the closing of the latest trading day, reflecting a +2.24% change compared to its last close.
HOLX's Enhanced Fibroid Treatment Portfolio Powers GYN Surgical Growth
Hologic's GYN Surgical segment gains momentum internationally as expanded fibroid treatments support growth.
Hologic Expands Panther Fusion's Menu With Diagnostic Innovation
HOLX expands its Panther Fusion platform with new GI bacterial assays, securing FDA and EU approvals to boost Diagnostics growth.
